01914nam 2200373 450 991068849760332120230628215313.010.5772/intechopen.83074(CKB)5400000000045435(NjHacI)995400000000045435(EXLCZ)99540000000004543520230628d2020 uy 0engur|||||||||||txtrdacontentcrdamediacrrdacarrierBiological Therapy for Inflammatory Bowel Disease /Raquel Franco Leal, Tristan Torriani, editorsLondon :IntechOpen,2020.1 online resource (140 pages)1-78985-954-9 Includes bibliographical references.The treatment of inflammatory bowel disease (IBD) has posed a major challenge since its appearance. Biomedical researchers, physicians, gastroenterologists, and surgeons have struggled to improve the quality of life of their patients and have sought, above all else, to keep the disease under remission for as long as possible. Blockers for tumoral necrosis factor alpha (TNF-α) were the first biological drugs to be discovered and for this reason they played a crucial role in the subsequent evolution of IBD treatment. The aim of this book is to provide an overview of such drugs and the latest developments in IBD immunopathology. Our contributors discuss the main indications, efficacy, and possible side effects of the different types of drugs available today for IBD treatment.Inflammatory bowel diseasesInflammatory bowel diseases.616.344Torriani TristanLeal Raquel FrancoNjHacINjHaclBOOK9910688497603321Biological Therapy for Inflammatory Bowel Disease2263313UNINA01303nam0 22003131i 450 UON0021472920231205103349.6034-7610-187-820030730d1979 |0itac50 bagerDE|||| |||||ˆDer ‰NeukantianismusHans-Ludwig OlligStuttgartJ.B. Metzlersche Verlagsbuchhandlung1979IX, 175 p.19 cm.001UON001738622001 Sammlung Metzler210 StuttgartWeimarMetzler.M 187CRITICISMOUONC045156FIKANTISMOUONC045157FINEOKANTISMOUONC045158FIDEWiesbadenUONL003153142Filosofia critica21OLLIGHans-LudwigUONV129737182374Metzlersche VerlagsbuchhandlungUONV266502650ITSOL20240220RICAUON00214729SIBA - SISTEMA BIBLIOTECARIO DI ATENEOSI FS 03440 SI FP 499 5 SIBA - SISTEMA BIBLIOTECARIO DI ATENEOSI TED 2 S.M. 187 SI LO 24072 5 187 Neukantianismus1262608UNIOR